A disease-modifying treatment for Parkinson’s is what our community urgently needs — one that targets the biological processes that cause symptoms to occur at all, slowing progression or stopping it in its tracks. There is still much work ahead, including clinical trials and regulatory approval. But the momentum is real: of the more than 170 Parkinson’s therapies currently in or nearing human trials, more than half are disease-modifying. Learn more about the future of Parkinson’s treatments: htt